Results 1 to 10 of about 20 (20)

Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer

International Journal of Molecular Sciences, 2023
Yu Huang, Yali Fan, Katherine Tucker
exaly  

The CDK1 inhibitor, Ro-3306, is a potential antiviral candidate against influenza virus infection

Antiviral Research, 2022
Lei Zhao, Yunzheng Yan, Qingsong Dai
exaly  

A specific inhibitor of CDK1, RO-3306, reversibly arrests meiosis during in vitro maturation of porcine oocytes

Animal Reproduction Science, 2014
Nam-Hyung Kim
exaly  

HLA-A* 3306, a novel variant in the Indian population

Tissue Antigens, 2002
N Mehra
exaly  

Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study

Lancet, The, 2017
Vinod S Hegade, Stuart Kendrick, Duncan Richards   +2 more
exaly  

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluations Following Single Oral Doses of GSK2330672 in Healthy Japanese Volunteers

Clinical Pharmacology in Drug Development, 2019
Stuart Kendrick
exaly  

Jumping the nuclear envelope barrier: Improving polyplex-mediated gene transfection efficiency by a selective CDK1 inhibitor RO-3306

Journal of Controlled Release, 2016
Xuefei Zhou, Xiangrui Liu, Dingcheng Zhu   +2 more
exaly  

Uptake of Compounds That Selectively Kill Multidrug-Resistant Cells: The Copper TransporterSLC31A1(CTR1) Increases Cellular Accumulation of the Thiosemicarbazone NSC73306

Molecular Pharmaceutics, 2014
Leung Fung, Kristen M Pluchino
exaly  

Influência da Taxa de Escalada da Energia Elétrica na Viabilidade dos Motores Industriais IR3 no Brasil [Not available in English]

2021
exaly  

Case 33062

New England Journal of Medicine, 1947
Tracy B Mallory, Edith E Parris, Arthur W Allen   +2 more
exaly